Ipamorelin vs CJC-1295 (without DAC)
Side-by-side comparison of evidence grade, dosage, safety, and stacking compatibility.
Growth Hormone Secretagogue
Ipamorelin
View full profile →
GHRH Analogue
CJC-1295 (without DAC)
View full profile →
Overview
Summary
Category
Evidence Grade
A = strongest
Safety Tier
A = safest
Dosage
Typical Dose
Low / High
Timing
Cycling
Goals & Use Cases
Primary Goals
Safety Profile
- •Active cancer or cancer history - GH promotes IGF-1 which is mitogenic
- •Diabetic retinopathy
- •Pregnancy
- •Competitive athletes - WADA prohibited substance
Contraindications
fewer = safer
- Active cancer - IGF-1 elevation is mitogenic•
- Diabetic retinopathy•
- Pregnancy•
- Competitive athletes - WADA prohibited•
Regulatory Status
Legal (US)
Legal (EU)
Can you take Ipamorelin and CJC-1295 (without DAC) together?
The standard GH optimisation stack. Inject both simultaneously before sleep. Most practitioners use 100-200mcg of each.
Ipamorelin mimics ghrelin at the GH secretagogue receptor (GHSR), triggering GH release. CJC-1295 is a GHRH analogue that simultaneously stimulates GHRH receptors. Activating both receptor types simultaneously produces synergistic GH pulse amplification - 3-5x greater GH release than either peptide alone.
Compare with other compounds